The Global Human Identification Market size is expected to reach $3.1 billion by 2030, rising at a market growth of 10.6% CAGR during the forecast period.
Next-generation sequencing (NGS) technology is increasingly utilized for conventional and non-conventional applications to obtain rapid and exhaustive genomic insights. Consequently, Next-generation sequencing segment is anticipated to acquire more than 15% share of the market by 2030. This is primarily because of advancements in this field's analytical solutions, services, and ancillary protocols. Consequently, adopting NGS in clinical workflows has witnessed favorable expansion prospects. High-throughput sequencers and portable devices are just two examples of the new technologies that have emerged due to the growing demand for reliable sequencing-based diagnostics. This has contributed to the recent rise of clinical NGS. Some of the factors impacting the market are Increasing number of forensic initiatives by governments, Rising DNA analysis demand, and High cost of genomic instruments and the shortage of skilled experts.
Methods of forensic human identification are used to determine the identities of individuals, typically in cases involving crime scenes, unidentified bodies, and missing persons. Some countries have developed national facial recognition programs to enhance security and identification. Some governments fund forensic anthropology and odontology programs to identify human remains through the analysis of skeletal remains, dental records, and bite marks. These programs assist in solving cold cases and disaster victim identification. These government-led forensic human identification programs vary in scope and sophistication, but they all contribute to the advancement of these technologies and, thus, drive the growth of the market. DNA testing is crucial for identifying the perpetrator and establishing justice in cases involving abandoned mothers and children. It is also a highly effective method in civil cases where the court needs to determine the issue of child support and identify the parents. The rising amount of DNA evidence gathered in criminal cases and the expanded effort to obtain DNA samples from convicted felons and arrested individuals are the two leading causes of the increased demand for DNA testing. This growing demand for DNA analysis is anticipated to contribute to expanding the market.
However, the high cost of genomic instruments and the absence of qualified professionals and trained personnel are anticipated to be significant market restraints during the forecast period for human identification. Without skilled and trained individuals, the instruments might not be used to their full potential, resulting in suboptimal performance and results. Adopting new technologies or approaches can be hampered by a lack of skilled personnel, limiting the scalability of human identification activities. As a result, market growth may slow down in the coming years.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Promega Corporation, Hamilton Company, Bio-Rad Laboratories, Inc, Qiagen N.V, SecuriGene Technologies Inc., AutoGen Inc., InnoGenomics Technologies, LLC., Carolina Biological Supply Company, and Genetek Biopharma GmbH
Next-generation sequencing (NGS) technology is increasingly utilized for conventional and non-conventional applications to obtain rapid and exhaustive genomic insights. Consequently, Next-generation sequencing segment is anticipated to acquire more than 15% share of the market by 2030. This is primarily because of advancements in this field's analytical solutions, services, and ancillary protocols. Consequently, adopting NGS in clinical workflows has witnessed favorable expansion prospects. High-throughput sequencers and portable devices are just two examples of the new technologies that have emerged due to the growing demand for reliable sequencing-based diagnostics. This has contributed to the recent rise of clinical NGS. Some of the factors impacting the market are Increasing number of forensic initiatives by governments, Rising DNA analysis demand, and High cost of genomic instruments and the shortage of skilled experts.
Methods of forensic human identification are used to determine the identities of individuals, typically in cases involving crime scenes, unidentified bodies, and missing persons. Some countries have developed national facial recognition programs to enhance security and identification. Some governments fund forensic anthropology and odontology programs to identify human remains through the analysis of skeletal remains, dental records, and bite marks. These programs assist in solving cold cases and disaster victim identification. These government-led forensic human identification programs vary in scope and sophistication, but they all contribute to the advancement of these technologies and, thus, drive the growth of the market. DNA testing is crucial for identifying the perpetrator and establishing justice in cases involving abandoned mothers and children. It is also a highly effective method in civil cases where the court needs to determine the issue of child support and identify the parents. The rising amount of DNA evidence gathered in criminal cases and the expanded effort to obtain DNA samples from convicted felons and arrested individuals are the two leading causes of the increased demand for DNA testing. This growing demand for DNA analysis is anticipated to contribute to expanding the market.
However, the high cost of genomic instruments and the absence of qualified professionals and trained personnel are anticipated to be significant market restraints during the forecast period for human identification. Without skilled and trained individuals, the instruments might not be used to their full potential, resulting in suboptimal performance and results. Adopting new technologies or approaches can be hampered by a lack of skilled personnel, limiting the scalability of human identification activities. As a result, market growth may slow down in the coming years.
End-user Outlook
By end user, the market is classified into forensic laboratories and research centers & academic government institutes. The research centers and academic government institutes segment recorded a remarkable revenue share in the market in 2022. Often, academic institutions conduct research on novel and enhanced methods, technologies, and techniques for human identification. In addition, they offer training for forensic experts, law enforcement personnel, and researchers on the appropriate use of these techniques in criminal investigations.Product Outlook
By product, the market is segmented into instruments, assay kits & reagents, and software. In 2022, the assay kits and reagents segment held the highest revenue share in the market. Regular and substantial purchases of assay kits and the introduction of new assay kits and reagents are expected to propel the growth of this market segment. Continuing research in genetics, genomics, and population studies enhances the demand for assay packages and reagents that facilitate high-throughput genetic analysis for various scientific studies.
Application Outlook
On the basis of application, the market is fragmented into forensic applications, paternity identification, and others. The paternity identification segment garnered a significant revenue share in the market in 2022. Paternity testing has been revolutionized by DNA analysis. The advancement of DNA sequencing and polymerase chain reaction technologies have made it possible to precisely compare the genetic makeup of individuals, including prospective fathers and children. Advances in genetics, technology, forensic science, and ethical considerations fuel the development of paternity human identification.Technology Outlook
Based on technology, the market is fragmented into polymerase chain reaction, next-generation sequencing, capillary electrophoresis, and others. In 2022, polymerase chain reaction (PCR) segment witnessed the largest revenue share in the market. The demand for polymerase chain reaction testing is expected to rise due to several important causes, including the growing use of PCR in forensic and research laboratories and the demand for advanced diagnostics. Furthermore, the introduction of novel technologies and an increase in contract research companies are projected to propel the demand for PCR testing throughout the projection period.Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The important share of this segment can be attributed to the expanding support for the development of forensics and the expansion of partnerships between universities in this region. Several factors are driving the growth of the critical players in the region, including increased funding from public and commercial sources, rising support for the development of forensics, and technological developments in the region.The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Promega Corporation, Hamilton Company, Bio-Rad Laboratories, Inc, Qiagen N.V, SecuriGene Technologies Inc., AutoGen Inc., InnoGenomics Technologies, LLC., Carolina Biological Supply Company, and Genetek Biopharma GmbH
Scope of the Study
By End-user
- Forensic Laboratories
- Research Centers, Academic & Government Institutes
By Product
- Assay Kits and Reagents
- Instruments
- Others
By Application
- Forensic Applications
- Paternity Identification
- Others
By Technology
- Polymerase Chain Reaction
- Next-Generation Sequencing
- Capillary Electrophoresis
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Hamilton Company
- Bio-Rad Laboratories, Inc
- Qiagen N.V
- SecuriGene Technologies Inc.
- AutoGen Inc.
- InnoGenomics Technologies, LLC.
- Carolina Biological Supply Company
- Genetek Biopharma GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Global Human Identification Market by End User
Chapter 6. Global Human Identification Market by Product
Chapter 7. Global Human Identification Market by Application
Chapter 8. Global Human Identification Market by Technology
Chapter 9. Global Human Identification Market by Region
Chapter 10. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Hamilton Company
- Bio-Rad Laboratories, Inc
- Qiagen N.V
- SecuriGene Technologies Inc.
- AutoGen Inc.
- InnoGenomics Technologies, LLC.
- Carolina Biological Supply Company
- Genetek Biopharma GmbH
Methodology
LOADING...
